AZB acts for Advent on 74% buy of Bharat Serums, Vaccines

Private equity firm Advent International (Advent) has signed a definitive agreement to acquire a majority interest in Bharat Serums and Vaccines Limited for an undisclosed sum. Bharat Serums is a biopharmaceutical player in women’s healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets. — Business Standard

AZB & Partners advised Advent International led by a team of partners Zia Mody, Darshika Kothari and Rinki Ganguli, and senior associates Pankhuri Govil and Devika Nayak.

2019-11-18

Deal value: Confidential

{incomplete}

Comments

No comments yet.